Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: J Rheumatol. 2011 Jun 17;38(7):1317–1325. doi: 10.3899/jrheum.100956

Table 3.

Cardiopulmonary diagnostic testing among 2300 SSc patients evaluated from 1990–2009.

Age of onset < 65 years Age of onset > 65 years p-value
Pulmonary Function Tests
No obstruction: FEV1/FVC ≥ 70% 1445/1808 (80%) 123/179 (69%) 0.001
 Mean ± SD* FEV1/FVC 0.79 ± 0.06 0.79 ± 0.06 0.109
 Mean ± SD minimum percent predicted FVC 69 ± 21 76 ± 22 0.001
 Mean ± SD minimum percent predicted TLC 78 ± 21 85 ± 26 0.001
 Mean ± SD minimum percent predicted DLCO 62 ± 26 65 ± 29 0.176
Obstruction: FEV1/FVC < 70% 363/1808 (20%) 56/179 (31%) 0.001
 Mean ± SD FEV1/FVC 0.62 ± 0.12 0.61 ± 0.09 0.654
 Mean ± SD minimum percent predicted FVC 70 ± 21 74 ± 17 0.129
 Mean ± SD minimum percent predicted TLC 83 ± 21 93 ± 26 0.002
 Mean ± SD minimum percent predicted DLCO 58 ± 23 54 ± 25 0.211
Echocardiography, mean ± SD
Minimum ejection fraction (n=1736) 56 ± 9 55 ± 10 0.133
Maximum RVSP, mmHg (n=1428) 44 ± 21 49 ± 20 0.007
Right heart cardiac catheterization measures
PA pressure ≥25mmHg and PCWP ≤15 mmHg 151 (7%)* 19 (9%)* 0.413
PA pressure ≥25mmHg and PCWP >15 mmHg 35 (2%)* 6 (3%)* 0.248
*

260 right heart catheterizations were completed among patients with younger SSc onset (< 65 years); and 35 right heart catheterizations were completed among patients with late-age SSc onset (≥ 65 years). The percentages represent number of catheterizations meeting criteria out of total number of younger SSc onset patients (n=2084) or late-age SSc onset patients (n=216).